ProCE Banner Activity

Navigating A New Therapeutic Era for HCC: Expert Review of New Agents and Guideline Recommendations

Slideset

Download this expert-authored slideset from a live symposium reviewing contemporary systemic treatment of advanced hepatocellular carcinoma.

Released: March 20, 2019

Expiration: March 18, 2020

Share

Faculty

Thomas A. Abrams

Thomas A. Abrams, MD

Institute Physician
Director, Liver Tumor Center
Dana-Farber Cancer Institute
Boston, Massachusetts

Stacey Stein

Stacey Stein, MD

Assistant Professor of Medicine
Yale University School of Medicine
Section of Medical Oncology
New Haven, Connecticut

Provided by

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by educational grants from:

Bayer Healthcare Pharma

Eisai

Partners

Clinical Care Options, LLC

ProCE Banner

Faculty Disclosure

Primary Author

Thomas A. Abrams, MD

Institute Physician
Director, Liver Tumor Center
Dana-Farber Cancer Institute
Boston, Massachusetts

Thomas A. Abrams, MD: consultant/advisor/speaker: AstraZeneca, Exelixis, Servier; researcher: Eisai.

Stacey Stein, MD

Assistant Professor of Medicine
Yale University School of Medicine
Section of Medical Oncology
New Haven, Connecticut